| Non-recurrence | Recurrence | P-value |
---|---|---|---|
Number | 25 | 23 | N/A |
Agea | 40.17 ± 11.87 | 43.16 ± 12.53 | 0.549 |
Gender | Â | Â | 0.971 |
 Male | 14 | 10 |  |
 Female | 11 | 13 |  |
Midline Invasion | Â | Â | 0.882 |
 Yes | 7 | 6 |  |
 No | 18 | 17 |  |
Lesion location | Â | Â | 0.571 |
 Frontal Lobe | 11 | 12 |  |
 Non-Frontal Lobe | 14 | 11 |  |
Lesion Size | Â | Â | 0.154 |
 <6 cm | 9 | 13 |  |
 ≥ 6 cm | 16 | 10 |  |
Lesion Margin | Â | Â | 0.010 |
 Sharp | 19 | 9 |  |
 Blurred | 6 | 14 |  |
Histological Classification | Â | Â | 0.309 |
 Astrocytoma | 18 | 16 |  |
 Oligodendroglioma | 3 | 6 |  |
 Unclear | 4 | 1 |  |
Pathological Grading | Â | Â | 0.020 |
 II | 11 | 17 |  |
 III | 14 | 5 |  |
Therapy after surgery | Â | Â | 0.428 |
 Chemotherapy and radiotherapy | 10 | 16 |  |
 Chemotherapy | 2 | 1 |  |
 Radiotherapy | 7 | 5 |  |
 Not clear | 6 | 3 |  |